Point72 Asset Management, L.P. 13D and 13G filings for Ventyx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:07 pm Sale | 2025-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 3,209,645 4.500% | -2,685,424 (-45.55%) | Filing |
| 2025-08-14 4:58 pm Purchase | 2025-06-30 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 5,895,069 8.300% | 1,494,744 (+33.97%) | Filing |
| 2025-01-29 6:58 pm Purchase | 2025-01-22 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 4,400,325 6.200% | 4,353,640 (+9325.56%) | Filing |
| 2024-11-14 7:54 pm Sale | 2024-09-30 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 46,685 0.100% | -2,970,408 (-98.45%) | Filing |
| 2024-02-23 4:28 pm Purchase | 2024-02-22 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 3,017,093 5.100% | 3,017,093 (New Position) | Filing |